Industry
Cancer Genetics Expands Access to Proprietary Diagnostics Through Agreement with Harvard Pilgrim
Under the terms of a new agreement between Cancer Genetics and Harvard Pilgrim Healthcare, a health care network covering over one million people throughout Massachusetts, Connecticut, and Maine, CGI will offer its cancer diagnostic services to individuals covered under Harvard Pilgrim plans. More...02 Aug 2015
Next Generation Sequencing Provides Responsiveness for Identifying Resistant Pathogens
According to a new market analysis, next generation sequencing may impact the infectious diseases IVD sector by bypassing some of the downside of PCR-based testing, as NGS can provide more flexibility and responsiveness in identification of new pathogenic strains. More...06 Jul 2015
Advanced NGS Partnership Paves Way for More Accessible Personalized Medicine in Cancer
New next generation sequencing test panels have been developed to provide more affordable advanced NGS testing that can help doctors choose the most effective cancer treatments based on tumor type and an individual’s genetic profile, an important step towards making personalized medicine broadly accessible. First launch is of a NGS colon cancer test panel. More...24 May 2015
In Other News
New Point of Care Test for Anemia Developed
Main Factors Driving Revenue Growth in Clinical Chemistry Identified
Bio-Rad Grants Beckman Coulter Exclusive Distribution for Two Infectious Disease Tests
Partnership to Offer New Coagulation Testing Solutions Worldwide
Clinical Lab Automation Sector at USD 5.4 Billion and Growing
Beyond Brazil, Latin American IVD Sector Grows
Improved Ebola IVD Tests Continue to Face Challenges
NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer
Microbiologics and Microbix Partner on Viral Controls for Diagnostics
Precision Makes dPCR a Steadily Growing Sector
Philips Collaborates with Janssen on Handheld Test for Neuropsychiatric Disorders
Latin America’s IVD Sector Exceeds USD 2 Billion, Brazil leads
“Softer” Mass Spec Techniques Gain Advantage in Biomarker Discovery
Sequencing-Based Testing Sector Already Highly Competitive
US Government Funding Initiative Includes Spotlight on Tissue Diagnostics
Lab-on-Paper Developed for Rapid Inexpensive Medical Diagnostics
Partnership Expands to Advance Novel Dual-Detection of Two Neglected Tropical Diseases
Healthcare Revolution Predicted with Rise of Genomic Testing for Personalized Medicine
Blood-Based Molecular Test Improves Early Detection of Colorectal Cancer
Social Network for Diagnostics Launched
Artel Expands Portfolio with STRATEC Partnership for Automation Technology
After First Approval of a Rapid Molecular Test, Expect More
Collaboration Agreement Targets Tumor-Related Genes
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.







